Research Article

Determinants of State Anxiety in Parents of Children with Lymphadenopathy: A Cross-Sectional Analysis

Volume: 40 Number: 1 January 28, 2026

Determinants of State Anxiety in Parents of Children with Lymphadenopathy: A Cross-Sectional Analysis

Abstract

Abstract Objective: Pediatric lymphadenopathy is common and usually benign, yet it may trigger substantial parental anxiety. We quantified parental state anxiety and examined clinical and psychosocial correlates, including online information-seeking. Methods: In a single-center cross-sectional study, parents of 99 consecutive children referred for lymphadenopathy completed the State-Trait Anxiety Inventory (STAI). The primary outcome was state anxiety (STAI-1); trait anxiety (STAI-2) was treated as a covariate. Child variables included age, sex, lymphadenopathy duration, and lymph node dimensions (short- and long-axis). Internet searching was recorded (yes/no) with perceived helpfulness. We used appropriate parametric/non-parametric tests, correlations, and multivariable linear regression modeling STAI-1 with age, sex, duration, short-axis, internet search, and STAI-2. Results: Children were 60.6% male; mean age 6.87±4.33 years. Median lymphadenopathy duration was 8.0 weeks; mean short-axis 9.47±3.67 mm and long-axis 22.17±7.37 mm. Epstein–Barr virus serology was negative in 98%. Mean parental STAI-1 and STAI-2 were 39.59±9.99 and 41.24±8.52. Internet searching (43.4% of parents) was not associated with higher STAI-1/2, and STAI scores did not differ by short-axis ≥10 mm. STAI-1 correlated negatively with duration (r=−0.204, p=0.045). In adjusted models, greater child age (B=0.660, p=0.002) and larger short-axis (B=0.562, p=0.019) independently predicted higher STAI-1, whereas longer duration predicted lower STAI-1 (B=−0.150, p=0.002); multicollinearity was negligible (VIF≈1). Conclusions: Among parents of children evaluated for lymphadenopathy, acute anxiety related more to objective node size and child age than to internet searching, while shorter symptom duration—reflecting greater uncertainty—was linked to higher anxiety. Structured counseling and clear follow-up plans may help effectively mitigate distress in lymphadenopathy clinics.

Keywords

Supporting Institution

İzmir Bakırçay University

Ethical Statement

The study protocol received approval from the İzmir Bakırçay University Ethics Committee (Approval No. 2302)

Thanks

The authors would like to thank Sezer Acar for helpful suggestions on the manuscript.

References

  1. 1. Cameron, D., Stetson, A., Blase, J., & Weldon, C. Pediatric Lymphadenopathy. Advances in pediatrics. 2025; 72.
  2. 2. Pecora, F., Abate, L., Scavone, S., Petrucci, I., Costa, F., Caminiti, C., et al. Management of Infectious Lymphadenitis in Children.Children. 2021; 8.
  3. 3. Spielberger CD, Gorsuch RL, Lushene R. Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press; 1970.
  4. 4. Julian LJ. Measures of anxiety: State-Trait Anxiety Inventory (STAI), Beck Anxiety Inventory (BAI), and Hospital Anxiety and Depression Scale-Anxiety (HADS-A). Arthritis Care Res. 2011;63(S11):S467-S472.
  5. 5. Pai AL, Greenley RN, Lewandowski A, et al. A meta-analytic review of the influence of pediatric cancer on parent and family functioning. J Fam Psychol. 2007;21(3):407-15.
  6. 6. Mess E, Misiąg W, Klaszczyk T, Kryś K. Depressive and Anxiety Disorders of Parents of Children with Cancer. Journal of Clinical Medicine. 2022;11(19):5670.
  7. 7. Boutin-Foster C, Foster JC, Konopasek L. Viewpoint: Physician, know thyself: The professional culture of medicine as a framework for teaching cultural competence. Acad Med. 2008;83(1):106-111.
  8. 8. Öner N, Le Compte A. State-trait anxiety inventory handbook. 2nd ed İstanbul: Boğaziçi University Press; 1985.

Details

Primary Language

English

Subjects

Clinical Sciences (Other)

Journal Section

Research Article

Publication Date

January 28, 2026

Submission Date

November 3, 2025

Acceptance Date

December 15, 2025

Published in Issue

Year 2026 Volume: 40 Number: 1

APA
Okur Acar, S., & Cansiz, M. A. (2026). Determinants of State Anxiety in Parents of Children with Lymphadenopathy: A Cross-Sectional Analysis. Developments and Experiments in Health and Medicine, 40(1), 111-121. https://izlik.org/JA68ME97WF
AMA
1.Okur Acar S, Cansiz MA. Determinants of State Anxiety in Parents of Children with Lymphadenopathy: A Cross-Sectional Analysis. Dev Exp Health Med. 2026;40(1):111-121. https://izlik.org/JA68ME97WF
Chicago
Okur Acar, Sultan, and Mehmet Akif Cansiz. 2026. “Determinants of State Anxiety in Parents of Children With Lymphadenopathy: A Cross-Sectional Analysis”. Developments and Experiments in Health and Medicine 40 (1): 111-21. https://izlik.org/JA68ME97WF.
EndNote
Okur Acar S, Cansiz MA (January 1, 2026) Determinants of State Anxiety in Parents of Children with Lymphadenopathy: A Cross-Sectional Analysis. Developments and Experiments in Health and Medicine 40 1 111–121.
IEEE
[1]S. Okur Acar and M. A. Cansiz, “Determinants of State Anxiety in Parents of Children with Lymphadenopathy: A Cross-Sectional Analysis”, Dev Exp Health Med, vol. 40, no. 1, pp. 111–121, Jan. 2026, [Online]. Available: https://izlik.org/JA68ME97WF
ISNAD
Okur Acar, Sultan - Cansiz, Mehmet Akif. “Determinants of State Anxiety in Parents of Children With Lymphadenopathy: A Cross-Sectional Analysis”. Developments and Experiments in Health and Medicine 40/1 (January 1, 2026): 111-121. https://izlik.org/JA68ME97WF.
JAMA
1.Okur Acar S, Cansiz MA. Determinants of State Anxiety in Parents of Children with Lymphadenopathy: A Cross-Sectional Analysis. Dev Exp Health Med. 2026;40:111–121.
MLA
Okur Acar, Sultan, and Mehmet Akif Cansiz. “Determinants of State Anxiety in Parents of Children With Lymphadenopathy: A Cross-Sectional Analysis”. Developments and Experiments in Health and Medicine, vol. 40, no. 1, Jan. 2026, pp. 111-2, https://izlik.org/JA68ME97WF.
Vancouver
1.Sultan Okur Acar, Mehmet Akif Cansiz. Determinants of State Anxiety in Parents of Children with Lymphadenopathy: A Cross-Sectional Analysis. Dev Exp Health Med [Internet]. 2026 Jan. 1;40(1):111-2. Available from: https://izlik.org/JA68ME97WF